The significance of an integrated multi-omics approach in psychiatric disorders: A pharmacological perspective

Eur Neuropsychopharmacol. 2024 Jan:78:64-66. doi: 10.1016/j.euroneuro.2023.09.008. Epub 2023 Nov 15.

Authors

Mojtaba Oraki Kohshour¹, Urs Heilbronner²

Affiliations

¹ Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, 80336, Munich, Germany; Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
² Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, 80336, Munich, Germany. Electronic address: Urs.Heilbronner@med.uni-muenchen.de.

PMID: 37977087
DOI: 10.1016/j.euroneuro.2023.09.008

No abstract available

MeSH terms

Computational Biology
Genomics
Humans
Mental Disorders* / drug therapy
Mental Disorders* / genetics
Multiomics*